Artículos científicos Open Access
Genome-wide CRISPR screening identifies TMEM106B as a proviral host factor for SARS-CoV-2
Nature Genetics
Baggen, J., Persoons, L., Vanstreels, E. et al.
The in-vitro effect of famotidine on sars-cov-2 proteases and virus replication
Sci Rep
Loffredo, M., Lucero, H., Chen, DY. et al.
Antibody Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7
Nature
Wang, P., Nair, M.S., Liu, L. et al
MRC5 cells engineered to express ACE2 serve as a model system for the discovery of antivirals targeting SARS-CoV-2
Sci Rep
Uemura, K., Sasaki, M., Sanaki, T. et al
Dynamic blood single-cell immune responses in patients with COVID-19
Sig Transduct Target Ther
Huang, L., Shi, Y., Gong, B. et al.
Deciphering the state of immune silence in fatal COVID-19 patients
Nat Commun
Bost, P., De Sanctis, F., Canè, S. et al.
A novel methodology for epidemic risk assessment of COVID-19 outbreak
Sci Rep
Pluchino, A., Biondo, A.E., Giuffrida, N. et al.
Metabolic health: a priority for the post-pandemic era
The Lancet Diabetes & Endocrinology
The Lancet Diabetes & Endocrinology
Global health security requires endemic disease eradication
The Lancet
Gretchen Newby, Winnie Mpanju-Shumbusho, Richard G A Feachem
COVID-19 and inhaled corticosteroids—another piece in an expanding puzzle
The Lancet Respiratory Medicine
Anna Schultze, Ian Douglas
IL-6 blockade for COVID-19: a global scientific call to arms
The Lancet Respiratory Medicine
Srinivas Murthy, Todd C Lee
Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial
The Lancet
PRINCIPLE Trial Collaborative Group, and others
Interferon antagonism by SARS-CoV-2: a functional study using reverse genetics
The Lancet Microbe
Simon Schroeder, Fabian Pott, Daniela Niemeyer, Talitha Veith, Anja Richter, Doreen Muth, and others
Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK
The Lancet Respiratory Medicine
Chloe I Bloom, Thomas M Drake, Annemarie B Docherty, Brian J Lipworth, Sebastian L Johnston, Jonathan S Nguyen-Van-Tam, and others
Tocilizumab plus standard care versus standard care in patients in India with moderate to severe COVID-19-associated cytokine release syndrome (COVINTOC): an open-label, multicentre, randomised, controlled, phase 3 trial
The Lancet Respiratory Medicine
Arvinder S Soin, Kuldeep Kumar, Narendra S Choudhary, Pooja Sharma, Yatin Mehta, Sushila Kataria, and others
